Association Between Carotid Plaque Length and Cardiovascular Outcomes

Sponsor
Changhai Hospital (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT05843487
Collaborator
Yueyang Hospital, Shanghai University of Traditional Chinese medicine (Other), Putuo Hospital, Shanghai University of Traditional Chinese Medicine (Other), No. 904 Hospital of the PLA Joint Logistics Support Force (Other), Gongli Hospital (Other)
3,000
5
168
600
3.6

Study Details

Study Description

Brief Summary

This multicenter study involved 5 hospitals (Changhai Hospital; Yueyang Hospital of Shanghai University of Traditional Chinese Medicine; Gongli Hospital; Putuo Hospital of Shanghai University of Traditional Chinese Medicine; No. 904 Hospital of the PLA Joint Logistics Support Force Wuxi). The study enrolled 5000 consecutive patients without known CAD who underwent first coronary angiography for stable chest pain and carotid ultrasound was performed during hospitalization from January 2017 through December 2018.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    Patients who had obstructive CAD (defined as ≥50% luminal stenosis) confirmed by coronary angiography and who underwent carotid scanning were included in the final analysis.Carotid ultrasonography was performed simultaneously, and carotid intima-media thickness (IMT), maximum thickness and length of all plaques were measured.The incidence of major adverse cardiovascular events was recorded during follow-up.

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    3000 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    Association Between Carotid Plaque Length and Cardiovascular Outcomes
    Actual Study Start Date :
    Jan 1, 2017
    Actual Primary Completion Date :
    Mar 31, 2022
    Anticipated Study Completion Date :
    Dec 31, 2030

    Arms and Interventions

    Arm Intervention/Treatment
    Carotid plaque length

    Patients underwent carotid ultrasonography and first coronary angiography simultaneously

    Outcome Measures

    Primary Outcome Measures

    1. major adverse cardiovascular events [3 years]

      cardiovascular death, myocardial infarction, ischemic stroke and coronary revascularization

    Secondary Outcome Measures

    1. all-cause death [3 years]

    2. cardiovascular death [3 years]

    3. myocardial infarction [3 years]

    4. ischemic stroke [3 years]

    5. coronary artery revascularization [3 years]

    6. heart failure [3 years]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Patients who underwent coronary angiography for stable chest pain and carotid ultrasound simultaneously;

    • Patients with obstructive CAD (≥50% coronary stenosis);

    Exclusion Criteria:
    • <18 years of age;

    • previous carotid surgery or significant carotid artery disease;

    • prior stroke or transient ischemic attack;

    • previously documented CAD (including history of myocardial infarction, acute coronary syndrome, or coronary revascularization);

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 No. 904 Hospital of the PLA Joint Logistics Support Force Wuxi Jiangsu China 214000
    2 Changhai Hospital Shanghai Shanghai China 200000
    3 Gongli Hospital Shanghai Shanghai China 200000
    4 Putuo Hospital Shanghai Shanghai China 200000
    5 Yueyang Hospital Shanghai Shanghai China 200000

    Sponsors and Collaborators

    • Changhai Hospital
    • Yueyang Hospital, Shanghai University of Traditional Chinese medicine
    • Putuo Hospital, Shanghai University of Traditional Chinese Medicine
    • No. 904 Hospital of the PLA Joint Logistics Support Force
    • Gongli Hospital

    Investigators

    • Principal Investigator: Pan Li, PhD, Changhai Hospital
    • Study Director: Jian Jian Na, MD, Putuo Hospital
    • Study Director: Liang Chen, MD, No. 904 Hospital of the PLA Joint Logistics Support Force
    • Study Director: Wei Zhang, MD, Gongli Hospital
    • Study Director: Yawei Yang, MD, Yueyang Hospital

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Changhai Hospital
    ClinicalTrials.gov Identifier:
    NCT05843487
    Other Study ID Numbers:
    • CPL
    First Posted:
    May 6, 2023
    Last Update Posted:
    May 6, 2023
    Last Verified:
    Jun 1, 2022
    Individual Participant Data (IPD) Sharing Statement:
    Undecided
    Plan to Share IPD:
    Undecided
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Changhai Hospital
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of May 6, 2023